MUNDIPHARMA RESEARCH LIMITED
Get an alert when MUNDIPHARMA RESEARCH LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£2M
-77.3% vs 2023
Net assets
£28M
+15.2% vs 2023
Employees
56
-18.8% vs 2023
Profit before tax
£5.9M
+79.3% vs 2023
Net assets
2-year trend · vs Industrials median
Accounts
2-year trend · Δ = latest vs prior filed period · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | Δ vs prior |
|---|---|---|---|---|
| Turnover | £39,716,000 | £51,889,000 | +30.7% | |
| Operating profit | £3,239,000 | £5,765,000 | +78% | |
| Profit before tax | £3,265,000 | £5,855,000 | +79.3% | |
| Net profit | £2,717,000 | £3,707,000 | +36.4% | |
| Cash | £8,870,000 | £2,017,000 | -77.3% | |
| Total assets less current liabilities | £24,462,000 | £28,185,000 | +15.2% | |
| Net assets | £24,462,000 | £28,185,000 | +15.2% | |
| Equity | £24,462,000 | £28,185,000 | +15.2% | |
| Average employees | 69 | 56 | -18.8% | |
| Wages | £7,959,000 | £7,904,000 | -0.7% | |
| Directors' remuneration | £953,000 | £1,441,000 | +51.2% |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating margin | 8.2% | 11.1% | |
| Net margin | 6.8% | 7.1% | |
| Return on capital employed | 13.2% | 20.5% | |
| Current ratio | 2.51x | 2.38x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 1 time since incorporation
- MUNDIPHARMA RESEARCH LIMITED 2006-08-23 → present
- NAPP PHARMACEUTICALS RESEARCH LIMITED 2002-12-04 → 2006-08-23
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Ernst & Young LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“Based on the directors' consideration of the ongoing contractual terms with customers, and forecasts that cover the period to 31 July 2026, the directors have prepared these financial statements on a going concern basis.”
Significant events
- “In May 2025, accounts receivable from a related party amounting to £28,000,000 were converted into a long-term interest-bearing loan. The loan is repayable at any time by agreement of the parties and earns interest at 5.31% per annum.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 15 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| JAMIESON, Stephen Johan | Director | 2019-02-22 | Sep 1957 | British |
| LEA, Bryan George | Director | 2020-01-01 | Jun 1961 | British |
| MARTINA, Yuri | Director | 2024-01-22 | Oct 1975 | British |
Show 15 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| KENDALL, Gareth | Secretary | 2002-12-04 | 2008-03-25 |
| CORNHILL SERVICES LIMITED | Corporate Secretary | 2008-03-25 | 2009-02-26 |
| SWIFT INCORPORATIONS LIMITED | Corporate Nominee Secretary | 2002-12-04 | 2002-12-04 |
| TIERCEL SERVICES LIMITED | Corporate Secretary | 2009-02-26 | 2018-06-11 |
| BAKER, Stuart David | Director | 2002-12-04 | 2019-12-31 |
| DUCHARME, Julie, Dr | Director | 2017-03-17 | 2019-07-04 |
| GOLDENHEIM, Paul David | Director | 2002-12-04 | 2004-04-30 |
| LEIGHTON-SCOTT, James Peter | Director | 2020-01-01 | 2020-09-30 |
| MANSARAY, Mohammed Gibril | Director | 2017-04-10 | 2019-07-26 |
| MATTESSICH, Antony | Director | 2011-05-19 | 2017-07-31 |
| MITCHELL, Christopher Benbow | Director | 2002-12-04 | 2018-04-12 |
| REIMER, Karen, Dr | Director | 2006-02-01 | 2017-03-31 |
| SHEEHAN, Brian James, Dr | Director | 2020-01-01 | 2024-01-22 |
| WIKSTROM, Ake Gunnar | Director | 2018-04-12 | 2019-02-22 |
| WIKSTROM, Ake Gunnar | Director | 2007-01-24 | 2011-05-19 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Mr Frank S. Vellucci | Individual | Appoints directors, Appoints directors (as trust) | 2023-11-03 | Active |
| Mr Rory A. Held | Individual | Appoints directors, Appoints directors (as trust) | 2023-11-03 | Active |
| Mr Daniel Connolly | Individual | Appoints directors, Appoints directors (as trust) | 2023-11-03 | Active |
| Mr Jeffrey Robins | Individual | Significant influence (as trust) | 2018-11-20 | Active |
| Mr Leslie John Schreyer | Individual | Significant influence (as trust) | 2018-11-20 | Active |
| Mrs Alexa Mairi Saunders | Individual | Significant influence (as trust) | 2018-03-05 | Active |
| Mr Stuart David Baker | Individual | Shares 25–50% | 2016-04-06 | Ceased 2019-09-04 |
| Mr Peter Minton Ward | Individual | Shares 25–50%, Significant influence (as trust) | 2016-04-06 | Ceased 2018-06-03 |
| Mr Christopher Benbow Mitchell | Individual | Significant influence (as trust) | 2016-04-06 | Ceased 2018-04-12 |
| Ms Hermance Bernadette Monique Schaepman | Individual | Significant influence (as trust) | 2016-04-06 | Active |
Filing timeline
Last 20 of 138 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2025-11-17 | CH01 | officers | Change person director company with change date | |
| 2025-09-09 | AA | accounts | Accounts with accounts type full | |
| 2025-06-13 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-02-06 | AD02 | address | Change sail address company with old address new address | |
| 2025-02-05 | AD01 | address | Change registered office address company with date old address new address | |
| 2024-12-03 | PSC01 | persons-with-significant-control | Notification of a person with significant control | |
| 2024-12-03 | PSC01 | persons-with-significant-control | Notification of a person with significant control | |
| 2024-12-03 | PSC01 | persons-with-significant-control | Notification of a person with significant control | |
| 2024-08-27 | AA | accounts | Accounts with accounts type full | |
| 2024-06-19 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-04-04 | CH01 | officers | Change person director company with change date | |
| 2024-02-26 | AP01 | officers | Appoint person director company with name date | |
| 2024-02-26 | TM01 | officers | Termination director company with name termination date | |
| 2023-10-02 | AA | accounts | Accounts with accounts type full | |
| 2023-06-17 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-01-07 | AA | accounts | Accounts with accounts type full | |
| 2022-09-05 | PSC01 | persons-with-significant-control | Notification of a person with significant control | |
| 2022-09-01 | PSC01 | persons-with-significant-control | Notification of a person with significant control | |
| 2022-09-01 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2022-07-04 | CH01 | officers | Change person director company with change date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 2
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.